
Christopher & Banks Corp. (NYSE: CBK) 23% HIGHER; reported Q3 EPS of $0.10, versus ($0.15) expected. Revenue for the quarter came in at $117.3 million versus the consensus estimate of $114.05 million.
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) 16% LOWER; announced the pricing of the underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $8.00 per share.
VeriSign, Inc. (NASDAQ: VRSN) 15% LOWER; Renewal of its .com license renewal with Internet Corporation for Assigned Names and Numbers (ICANN). Under the agreement, VeriSign will have its $7.85 per domain pricing locked